It was noteworthy that CAD per se was associated with lower BDNF levels in our study, independent of antiplatelet treatment, and that the presence of CAD significantly influenced the relationship between platelet activity and circulating BDNF levels. This evidence concerns the gene BDNF and coronary artery disorder.